Werewolf Therapeutics Inc (HOWL)

Jul 27, 2026

Werewolf Therapeutics (HOWL) Stock Forum and Discussion - Moomoo

Jul 27, 2026

Jul 27, 2026

HOWL|Werewolf Therapeutics Inc|Price:0.427|Chg%:+0.067 - TradingKey

Jul 27, 2026

Jul 27, 2026

Werewolf Therapeutics Inc (HOWL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026

Jul 26, 2026

TradingKey - TradingKey

Jul 26, 2026

Jul 26, 2026

Werewolf Therapeutics Inc (HOWL) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 26, 2026

Jul 25, 2026

Werewolf Therapeutics, Inc. Revenue Breakdown – NASDAQ:HOWL - TradingView

Jul 25, 2026

Jul 24, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Jul 24, 2026

Jul 24, 2026

Werewolf Therapeutics Inc (HOWL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026

Jul 22, 2026

HOWL stock gains on latest Wolfpack earnings context - Ad-hoc-news.de

Jul 22, 2026

Jul 20, 2026

HOWL stock trades on fresh data from Werewolf Therapeutics cancer pipeline - Ad-hoc-news.de

Jul 20, 2026

Jul 15, 2026

Werewolf Therapeutics (HOWL) Q1 2026 Earnings: Narrower Loss Surprises as Biotech Navigates Early Pipeline MilestonesGross Profit Margin - dars.gov.et

Jul 15, 2026

Jul 12, 2026

Price to earnings forward of Werewolf Therapeutics, Inc. – NASDAQ:HOWL - TradingView

Jul 12, 2026

Jul 10, 2026

Frontier tech research, news & data - MLQ.ai

Jul 10, 2026

Jul 09, 2026

HOWL stock stays in focus as Werewolf Therapeutics pursues immuno-oncology pipeline - ad-hoc-news.de

Jul 09, 2026

Jul 08, 2026

Werewolf Therapeutics director Luke Evnin sells $44,749 in stock By Investing.com - Investing.com Nigeria

Jul 08, 2026

Jul 08, 2026

Form 4 Werewolf Therapeutics Inc For: 8 July By Investing.com - Investing.com Nigeria

Jul 08, 2026

Jul 08, 2026

Werewolf Therapeutics director Luke Evnin sells $44,749 in stock - Investing.com

Jul 08, 2026

Jul 08, 2026

Werewolf Therapeutics (HOWL) director-linked funds sell 143,199 shares - Stock Titan

Jul 08, 2026

Jul 07, 2026

Werewolf Therapeutics outlines its immuno-oncology strategy as Nasdaq-listed biotech - ad-hoc-news.de

Jul 07, 2026

Jul 06, 2026

Form 144 Werewolf Therapeutics For: 6 July By Investing.com - Investing.com Nigeria

Jul 06, 2026

Jul 06, 2026

[144] Werewolf Therapeutics, Inc. SEC Filing - Stock Titan

Jul 06, 2026

Jul 06, 2026

Werewolf Therapeutics, Inc. SEC Filing (Jul 6, 2026) - Stock Titan

Jul 06, 2026

Jul 02, 2026

RA Capital trims Werewolf Therapeutics (HOWL) stake below 5% threshold - Stock Titan

Jul 02, 2026

Jul 02, 2026

Form 13D/A WEREWOLF THERAPEUTICS For: 2 July By Investing.com - Investing.com South Africa

Jul 02, 2026

Jul 02, 2026

Werewolf Therapeutics (HOWL) price target increased by 20.19% to 6.38 - MSN

Jul 02, 2026

Jul 01, 2026

Werewolf Therapeutics, Inc. Financial Disclosures & SEC Filings - TradingView

Jul 01, 2026

Jun 30, 2026

Werewolf Therapeutics director Luke Evnin sells $47,125 in stock By Investing.com - Investing.com Australia

Jun 30, 2026

Jun 29, 2026

Form 4 Werewolf Therapeutics Inc For: 29 June By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

Form 144 Werewolf Therapeutics For: 29 June By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

Werewolf Therapeutics director Luke Evnin sells $47,125 in stock - Investing.com

Jun 29, 2026

Jun 29, 2026

Entities tied to Werewolf Therapeutics (HOWL) director Luke Evnin sell 157K shares - Stock Titan

Jun 29, 2026

Jun 27, 2026

Werewolf Therapeutics, Inc. Actuals & Estimates (NASDAQ:HOWL) - TradingView

Jun 27, 2026

Jun 27, 2026

Form 13D/A WEREWOLF THERAPEUTICS For: 26 June By Investing.com - Investing.com South Africa

Jun 27, 2026

Jun 27, 2026

Werewolf Therapeutics Inc (HOWL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 27, 2026

Jun 26, 2026

RA Capital reports 6% Werewolf Therapeutics (HOWL) stake after June share sales - Stock Titan

Jun 26, 2026

Jun 26, 2026

Werewolf Therapeutics details cancer pipeline progress, shares watched by biotech investors - ad-hoc-news.de

Jun 26, 2026

Jun 24, 2026

Werewolf Therapeutics Inc (HOWL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 24, 2026

Jun 23, 2026

Werewolf Therapeutics Inc (HOWL) Institutional Confidence - TradingKey

Jun 23, 2026

Jun 22, 2026

Ra Capital sells $145,918 of Werewolf Therapeutics (HOWL) stock By Investing.com - Investing.com Australia

Jun 22, 2026

Jun 22, 2026

Ra Capital sells $145,918 of Werewolf Therapeutics (HOWL) stock - Investing.com UK

Jun 22, 2026

Jun 22, 2026

[SCHEDULE 13D/A] Werewolf Therapeutics, Inc. Amended Major Shareholder Report - Stock Titan

Jun 22, 2026

Jun 22, 2026

Form 13D/A WEREWOLF THERAPEUTICS For: 22 June By Investing.com - Investing.com South Africa

Jun 22, 2026

Jun 22, 2026

Form 4 Werewolf Therapeutics Inc For: 22 June By Investing.com - Investing.com Nigeria

Jun 22, 2026